Navigation Links
Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results
Date:3/11/2011

ber 31, 2010 includes $3.1 million related to the departure of certain employees.Condensed Consolidated Balance Sheet Data(in thousands)December 31,

2010December 31,

2009Cash, cash equivalents and short-term investments

$

80,612$

50,891Total assets

$

100,454$

55,065Total stockholders' equity

$

77,123$

24,741About Ardea Biosciences, Inc.Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases.  Lesinurad, previously called RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a once-daily, oral inhibitor of the URAT1 transporter which has completed Phase 2 clinical development.  Our next-generation URAT1 inhibitor program is currently in preclinical development.  BAY 86-9766, formerly known as RDEA119, is a potent and specific inhibitor of mitogen-activated ERK kinase (MEK) for the treatment of cancer being developed under a global license agreement with Bayer HealthCare AG.  BAY 86-9766 is currently in a Phase 2 study in patients with hepatocellular carcinoma in combination with sorafenib (Nexavar®; Bayer, Onyx Pharmaceuticals) and a Phase 1/2 study in patients with advanced pancreatic cancer in combination with gemcitabine.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.  Such statements include, but are not limited to, statements regarding our plans and goals, the expected properties and benefits of lesinurad, BAY 86-9766 and our other compounds and the timing and results of our precl
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
2. Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting
3. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
4. Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools
5. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
6. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
7. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
8. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
9. Ardea Biosciences to Present at Two Upcoming Investor Conferences
10. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
11. Ardea Biosciences Prices Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Hussey Copper , ... 29 antimicrobial copper announces Pullman Regional Hospital,s conversion ... EPA-registered antimicrobial solid touch surface, at a nominal cost.  ... MRSA, E-coli and other bacteria within 2 hours of exposure ... against bacteria and infectious diseases in its facilities. ...
(Date:7/22/2014)... Mass. , July 22, 2014  The ... $650 million from philanthropist Ted Stanley ... and bringing new treatments based on molecular understanding ... world. The Stanley commitment – ... the largest for scientific research in general – ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Holomic ... with the debut of its fluorescent immunoassay reader, ... Chemistry (AACC) meeting in Chicago, July 28-31, 2014. ... top versions, the HRDR-300 is a highly sensitive, ... to analyze fluorescent lateral flow immunoassays with high ...
(Date:7/22/2014)... The next session of Clinovo’s ... will comprise of the increasingly popular ‘Base SAS’ and ... a series of technical hands-on classes for entry-level to ... the next step in their professional careers. , The ... Jennifer Kang, Senior Statistician at Genentech and former Senior ...
Breaking Biology Technology:Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 4$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 5$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 6$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 7$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 8$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 9$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 10Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3
... of electrospinning for applications primarily within the medical device ... announces a new technology platform in the field of ... ranging from the nano to microscale. Zeus is able ... and bioabsorbables. The result is a broad range of ...
... Zeus is slated to manufacture parts and assemble MOD® units, an ... ... Orangeburg, SC (PRWEB) February 15, 2009 -- Zeus, Inc., a ... pleased to announce a new partnership with Avancen MOD Corporation. ...
... free webinars providing continuing education for Chemists and Chemical Engineers. Visit ... as a listing of over sixty On-Demand Webinars. For your convenience, the ... , ... Columbia, MD (PRWEB) February 14, 2009 -- Each free ...
Cached Biology Technology:Electrospinning: Emerging New Technology at Zeus 2Zeus Partners with Avancen MOD Corp. 2Free Webinars in Chemistry and Chemical Engineering 2
(Date:7/22/2014)... will hear that drinking milk helps make their bones strong or ... foster the idea that if something is good for us, it ... Journal of Consumer Research , when children hear about the ... "We predicted that when food is presented to children as making ... as learning how to read or count, they would conclude the ...
(Date:7/22/2014)... and Shenzhen, China July 22, 2014 ... subsidiary of BGI, the world,s largest genomics organization, ... human whole exome sequencing service based on Complete ... in-depth bioinformatics analysis and SNP validation, and is ... , Complete Genomics, highly regarded in the ...
(Date:7/22/2014)... -- Nancy Buccola, MSN, APRN, PMHCNS-BC, CNE, Assistant ... Center New Orleans School of Nursing, contributed samples ... genetic material associated with schizophrenia and also suggesting ... schizophrenia. The study, Biological insights from 108 schizophrenia-associated ... in Nature , available at http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13595.html., ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2
... a growing body of evidence that continued smoking after a ... survival, risk of other cancers, and quality of life, up ... so or relapse after trying to quit. , The ... a peer-reviewed journal of the American Cancer Society, says smoking ...
... GI infections in families with children in day careUsing an ... infections in the home, according to a study in the ... Greater Boston families -- half of which were given hand ... percent reduction in the spread of GI illnesses. , ...
... how the inhaled form of anthrax disarms bacteria-fighting white blood ... most victims within days. , The lethal toxin in anthrax ... body's first defense against infection, by impairing how they build ... body and eat invading bacteria. , Just two hours of ...
Cached Biology News:Many smokers fail to quit after cancer diagnosis 2Hand sanitizer gel works 2Anthrax stops body from fighting back, study shows 2Anthrax stops body from fighting back, study shows 3
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z71,669-3) ... assistance. ID clarifier: barcoded Mfr ...
Rabbit polyclonal to YANK2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide selected within aa 300~400 (C terminal region) of human YANK2. Entrez Gene ID:...
... Freedom EVO96R and Freedom EVO384R are fast ... available in three different sizes, with a ... They deliver significant time saving, with true ... easy setup of your assays with the ...
Request Info...
Biology Products: